Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ifrah

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Leukemia|October 23, 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicinP Chevallier, T Prebet, A Pigneux, et al.
Leukemia|July 4, 2012
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALLL Lhermitte, R Ben Abdelali, P Villarèse, et al.
Leukemia|June 13, 2008
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AMLS Park, N Chapuis, V Bardet, et al.
Leukemia|June 9, 2017
TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcomeP Villarese, C Lours, A Trinquand, et al.
Blood|August 15, 1996
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter studyE Solary, B Witz, D Caillot, et al.
British Journal of Haematology|June 1, 1997
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)G Socié, J Y Cahn, J Carmelo, et al.
Blood Cancer Journal|August 29, 2015
Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significanceJ M Piot, M Royer, A Schmidt-Tanguy, et al.
Leukemia|October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie CellulaireM Mohty, M Labopin, M L Balère, et al.
Cytometry. Part B, Clinical Cytometry|October 2, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyC Fossat, M Roussel, I Arnoux, et al.
British Journal of Haematology|February 14, 2002
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemiaA Pigneux, M L Tanguy, M Michallet, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Leukemia|October 23, 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicinP Chevallier, T Prebet, A Pigneux, et al.
Leukemia|July 4, 2012
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALLL Lhermitte, R Ben Abdelali, P Villarèse, et al.
Leukemia|June 13, 2008
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AMLS Park, N Chapuis, V Bardet, et al.
Leukemia|June 9, 2017
TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcomeP Villarese, C Lours, A Trinquand, et al.
Blood|August 15, 1996
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter studyE Solary, B Witz, D Caillot, et al.
British Journal of Haematology|June 1, 1997
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)G Socié, J Y Cahn, J Carmelo, et al.
Blood Cancer Journal|August 29, 2015
Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significanceJ M Piot, M Royer, A Schmidt-Tanguy, et al.
Leukemia|October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie CellulaireM Mohty, M Labopin, M L Balère, et al.
Cytometry. Part B, Clinical Cytometry|October 2, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyC Fossat, M Roussel, I Arnoux, et al.
British Journal of Haematology|February 14, 2002
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemiaA Pigneux, M L Tanguy, M Michallet, et al.
Pageof 13